158 related articles for article (PubMed ID: 18633172)
1. Telmisartan, an angiotensin II type 1 receptor blocker, improves coronary microcirculation and insulin resistance among essential hypertensive patients without left ventricular hypertrophy.
Hinoi T; Tomohiro Y; Kajiwara S; Matsuo S; Fujimoto Y; Yamamoto S; Shichijo T; Ono T
Hypertens Res; 2008 Apr; 31(4):615-22. PubMed ID: 18633172
[TBL] [Abstract][Full Text] [Related]
2. Angiotensin receptor blocker improves coronary flow velocity reserve in hypertensive patients: comparison with calcium channel blocker.
Kamezaki F; Tasaki H; Yamashita K; Shibata K; Hirakawa N; Tsutsui M; Kouzuma R; Nagatomo T; Adachi T; Otsuji Y
Hypertens Res; 2007 Aug; 30(8):699-706. PubMed ID: 17917317
[TBL] [Abstract][Full Text] [Related]
3. Effect of nifedipine versus telmisartan on prevention of atrial fibrillation recurrence in hypertensive patients.
Du H; Fan J; Ling Z; Woo K; Su L; Chen S; Liu Z; Lan X; Zhou B; Xu Y; Chen W; Xiao P; Yin Y
Hypertension; 2013 Apr; 61(4):786-92. PubMed ID: 23438932
[TBL] [Abstract][Full Text] [Related]
4. Telmisartan at 80 mg/day increases high-molecular-weight adiponectin levels and improves insulin resistance in diabetic patients.
Mori H; Okada Y; Arao T; Nishida K; Tanaka Y
Adv Ther; 2012 Jul; 29(7):635-44. PubMed ID: 22821644
[TBL] [Abstract][Full Text] [Related]
5. Effects of telmisartan and losartan on insulin resistance in hypertensive patients with metabolic syndrome.
Bahadir O; Uzunlulu M; Oguz A; Bahadir MA
Hypertens Res; 2007 Jan; 30(1):49-53. PubMed ID: 17460371
[TBL] [Abstract][Full Text] [Related]
6. Influence of telmisartan on insulin response after glucose loading in obese patients with hypertension: ARB trial of hypertension in obese patients with hyperinsulinemia assessed by oral glucose tolerance test (ATHLETE).
Mori Y; Tanaka T; Matsuura K; Yokoyama J; Utsunomiya K
Adv Ther; 2011 Aug; 28(8):698-706. PubMed ID: 21744143
[TBL] [Abstract][Full Text] [Related]
7. Telmisartan lowers home blood pressure and improves insulin resistance without correlation between their changes.
Kobayashi K; Ohno Y; Takenaka T; Ikeda N; Okada H; Kanno Y; Suzuki H
Clin Exp Hypertens; 2011; 33(2):100-5. PubMed ID: 21269058
[TBL] [Abstract][Full Text] [Related]
8. Effect of telmisartan on QT interval variability and autonomic control in hypertensive patients with left ventricular hypertrophy.
Galetta F; Franzoni F; Fallahi P; Tocchini L; Graci F; Carpi A; Antonelli A; Santoro G
Biomed Pharmacother; 2010 Oct; 64(8):516-20. PubMed ID: 20044234
[TBL] [Abstract][Full Text] [Related]
9. The effects of simvastatin on left ventricular hypertrophy and left ventricular function in patients with essential hypertension.
Pan XD; Zeng ZH; Liang LY; Luo JD; Xiao AY; Lai Q; Wen YH; Lu DF; Wang W; He ZC; He WK
Clin Exp Hypertens; 2011; 33(8):558-64. PubMed ID: 21957976
[TBL] [Abstract][Full Text] [Related]
10. Telmisartan improves insulin sensitivity in nondiabetic patients with essential hypertension.
Benndorf RA; Rudolph T; Appel D; Schwedhelm E; Maas R; Schulze F; Silberhorn E; Böger RH
Metabolism; 2006 Sep; 55(9):1159-64. PubMed ID: 16919533
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin II receptor blocker telmisartan: effect on blood pressure profile and left ventricular hypertrophy in patients with arterial hypertension.
Ivanova OV; Fomicheva OA; Sergakova LM; Chernova NA; Rogoza AN; Karpov YA
J Int Med Res; 2005; 33 Suppl 1():21A-29A. PubMed ID: 16222897
[TBL] [Abstract][Full Text] [Related]
12. [Antihypertensive and organ-protective action of a 36-week monotherapy with telmisartan in hypertensive patients].
Petriĭ VV; Sergushkina NG; Brazhnik VA; Makolkin VI
Ter Arkh; 2008; 80(12):13-6. PubMed ID: 19227900
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the effects of telmisartan and nifedipine gastrointestinal therapeutic system on blood pressure control, glucose metabolism, and the lipid profile in patients with type 2 diabetes mellitus and mild hypertension: a 12-month, randomized, double-blind study.
Derosa G; Cicero AF; Bertone G; Piccinni MN; Fogari E; Ciccarelli L; Fogari R
Clin Ther; 2004 Aug; 26(8):1228-36. PubMed ID: 15476904
[TBL] [Abstract][Full Text] [Related]
14. Telmisartan reduced blood pressure and HOMA-IR with increasing plasma leptin level in hypertensive and type 2 diabetic patients.
Usui I; Fujisaka S; Yamazaki K; Takano A; Murakami S; Yamazaki Y; Urakaze M; Hachiya H; Takata M; Senda S; Iwata M; Satoh A; Sasaoka T; Ak ND; Temaru R; Kobayashi M
Diabetes Res Clin Pract; 2007 Aug; 77(2):210-4. PubMed ID: 17240472
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of three angiotensin II receptor type 1 blockers on metabolic parameters in hypertensive patients with type 2 diabetes mellitus.
Ozaki N; Nomura Y; Sobajima H; Kondo K; Oiso Y
Eur J Intern Med; 2010 Jun; 21(3):236-9. PubMed ID: 20493430
[TBL] [Abstract][Full Text] [Related]
16. Telmisartan improves insulin resistance in high renin nonmodulating salt-sensitive hypertensives.
Sanchez RA; Masnatta LD; Pesiney C; Fischer P; Ramirez AJ
J Hypertens; 2008 Dec; 26(12):2393-8. PubMed ID: 19008718
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of an angiotensin II receptor blocker and a long-acting calcium channel blocker against cardiovascular organ injuries in hypertensive patients.
Ishimitsu T; Kobayashi T; Honda T; Takahashi M; Minami J; Ohta S; Inada H; Yoshii M; Ono H; Matsuoka H
Hypertens Res; 2005 Apr; 28(4):351-9. PubMed ID: 16138566
[TBL] [Abstract][Full Text] [Related]
18. Improvement of endothelial function in patients with hypertension and type 2 diabetes after treatment with telmisartan.
Wago T; Yoshimoto T; Akaza I; Tsuchiya K; Izumiyama H; Doi M; Hirata Y
Hypertens Res; 2010 Aug; 33(8):796-801. PubMed ID: 20555330
[TBL] [Abstract][Full Text] [Related]
19. Improvement of coronary flow velocity reserve with telmisartan in patients with autosomal-dominant polycystic kidney disease.
Alisir S; Turkmen K; Alpay N; Elitok A; Oflaz H; Uslu B; Cimen A; Kasikcioglu E; Tufan F; Ecder T
South Med J; 2010 May; 103(5):409-13. PubMed ID: 20375940
[TBL] [Abstract][Full Text] [Related]
20. The angiotensin II receptor blocker telmisartan improves insulin resistance and has beneficial effects in hypertensive patients with type 2 diabetes and poor glycemic control.
Yamana A; Arita M; Furuta M; Shimajiri Y; Sanke T
Diabetes Res Clin Pract; 2008 Oct; 82(1):127-31. PubMed ID: 18692932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
